Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AMPK gene therapy is a regenerative medicine intervention developed by Integrated Health Systems (IHS). It involves the upregulation or activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. By increasing AMPK signaling, the therapy aims to enhance glucose metabolism, improve mitochondrial efficiency, and balance nutrient supply with energy demand. It is positioned as a preventative treatment for metabolic dysfunction and various age-related conditions, focusing on slowing or reversing the aging process at a cellular level. Unlike traditional pharmaceuticals, this therapy is offered as part of a medical concierge service specializing in anti-aging and regenerative treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AMPK gene therapy (Integrated Health Systems).